Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-31 @ 5:12 PM
Study NCT ID:
NCT00109161
Status:
COMPLETED
Last Update Posted:
2008-08-05
First Post:
2005-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Sponsor:
PDL BioPharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-10
Completion Date Type:
None
First Submit Date:
2005-04-22
First Submit QC Date:
None
Study First Post Date:
2005-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-08-02
Last Update Post Date:
2008-08-05
Last Update Post Date Type:
ESTIMATED